Company / Operating Cash Flow
Bio-Techne Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$287.6M
FY2025
5-year range
$181.6M / $352.2M
FY2021-FY2025
Trend
-3.8%
vs FY2024
Sector context
#69 of 164
Health Care
What the data says
At $288M, Bio-Techne's operating cash flow ranks #69 of 164 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $144M in FY2017 to $352M in FY2023.
Based on SEC 10-K filings.
$288M in FY2025 with a 5-year CAGR of +7.0%.
Declined from $352M to $288M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#69 of 164 in Health CareTop 42% of 164This company $287.6M Sector average $1.0B
▼
-72.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, operating cash flow decreased 3.8% year-over-year.
- Ranks #69 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.6M | -3.8% |
| FY2024 | $299.0M | -15.1% |
| FY2023 | $352.2M | +71.6% |
| FY2022 | $205.2M | +13.0% |
| FY2021 | $181.6M | -11.5% |
| FY2020 | $205.2M | +13.0% |
| FY2019 | $181.6M | +6.6% |
| FY2018 | $170.4M | +18.5% |
| FY2017 | $143.7M | -0.3% |
| FY2016 | $144.2M | +3.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026